Applied Genetic Technologies (NASDAQ:AGTC) is up 3.8% postmarket following an initiation at Buy by Roth Capital.
Roth’s Jallah Zegbeh sees 218% upside, setting a
price target of $25; shares had closed up 6.2% against today’s down
market, to $7.86.
https://seekingalpha.com/news/3534971-applied-geneticsplus-3_8-roth-starts-buy
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.